Study of the Nutraceutical Properties and Health Benefits of Traditional Components of the Mediterranean Diet
Launched by UNIVERSITY OF ROME TOR VERGATA · Jun 26, 2013
Trial Information
Current as of June 24, 2025
Unknown status
Keywords
ClinConnect Summary
This study envisages the enrollment of subjects, to be recruited consecutively from May 2013 to May 2015 from the staff of the laboratory of the Evaluation of Nutritional State, Nutrigenetics and nutrigenomics of the Human Nutrition and Diet section of the University of Rome Tor Vergata.
The study will be conducted in accordance with the Declaration of Helsinki, and approved by the Committee of the Ministero delle Politiche Alimentari e Forestali (MIPAAF) , Italy, approved by DM 06/12/2011 n° prot. 32064. All participants will be required to provide written informed consent for the study.
...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:Age:
- • 18 to 75 years inclusive BMI \>19 kg/m2
- • -
- Exclusion Criteria:
- • Past history of ischaemic coronary artery disease
- • Peripheral or cerebral vasculopathy
- • Hepatic disease
- • Diabetes Mellitus
- • Autoimmune disease
- • HIV/AIDS
- • Neoplastic disease
- • Use of the following medications: lipid-lowering medications, oral anti-diabetic medication or insulin, nitroglycerin, corticosteroids.
About University Of Rome Tor Vergata
The University of Rome Tor Vergata is a prestigious academic institution recognized for its commitment to advancing medical research and education. As a clinical trial sponsor, it leverages its extensive resources and expertise in various fields of health sciences to foster innovative research initiatives. The university collaborates with healthcare professionals, researchers, and industry partners to conduct rigorous clinical trials aimed at improving patient care and outcomes. With a focus on ethical standards and scientific integrity, the University of Rome Tor Vergata is dedicated to contributing to the global body of medical knowledge and translating research findings into practical applications for the benefit of society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rome, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials